相关实验视频
Updated: Jan 11, 2026
Bone Marrow Sampling and Transplants
在心脏手术中进行治疗点血静检测:一个阶段性结合的随机对照试验
Keyvan Karkouti1, Jeannie Callum2, Duminda N Wijeysundera2
1From Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, University of Toronto, Canada (K.K.); Department of Laboratory Medicine and Pathobiology, Sunnybrook Health Sciences Centre, University of Toronto, Canada (J.C.); Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, University of Toronto, and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Canada (D.N.W.); Division of Cardiac Surgery, Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Canada (V.R.); Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada (M.C.); Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, Canada (H.P.G.); Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada (R.P.); Department of Critical Care Medicine, Sunnybrook Health Sciences Centre and Interdepartmental Division of Critical Care, University of Toronto, Canada (D.C.S.); and the Peter Munk Cardiac Centre, University Health Network, Toronto, Canada (K.K., D.N.W., V.R.). keyvan.karkouti@uhn.ca.
在心脏外科手术中的血静测试显著减少了红细胞和血小板输血. 这种方法还减少了主要的出血事件,改善了患者的结果.
科学领域:
- 麻醉学
- 血液学
- 手术科学
背景情况:
- 凝固性出血是心脏手术中常见的并发症,
- 标准静脉检测的局限性需要改进治疗出血疾病的方法.
- 护理点 (POC) 测试为实时评估血静提供了一个潜在的解决方案.
研究的目的:
- 评估POC静脉检测是否集成到输血算法中可以改善凝血病的治疗.
- 确定这种综合方法是否会减少心脏手术患者的输血产品.
- 评估对严重出血和其他并发症的影响.
主要方法:
- 进行了一项实用,多中心,阶梯集群的随机对照试验.
- 在12个医院连续实施了使用POC静血测试的输血算法.
- 主要结局是从手术到术后7天的红细胞输血率.
主要成果:
- 这项干预措施使红细胞输血率降低了9% (RR,0. 91;P=0. 02).
- 血小板输血率降低了23% (RR,0. 77;P< 0. 001) 和大出血率降低了17% (RR,0. 83;P=0. 004).
- 没有观察到对其他血液制品输血或重大并发症的显著影响.
结论:
- 在输血算法中实施POC血静测试有效地减少了心脏手术中的输血和严重出血.
- 这些发现支持POC血静测试的更广泛的临床采用.
- 通过POC测试优化血静管理可以提高患者的安全性和资源利用率.